Purchase this report

Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Infections (Infectious Disease) - Drugs in Development, 2021

Published	Pages	Publisher	Report code
Apr 2021	30	Global Markets Direct	ASDR-577708

Published: Apr 2021 - Pages : 30 - Publisher : Global Markets Direct - Report code : ASDR-577708

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Published: September, 2021 - Pages: 462 - US$ 2,500.00
Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Published: December, 2021 - Pages: 62 - US$ 2,000.00
Zika Virus Infections (Infectious Disease) - Drugs in Development, 2021 Published: December, 2021 - Pages: 258 - US$ 2,000.00
Influenza A Virus, H7N9 Subtype Infections (Infectious Disease) - Drugs in Development, 2021 Published: December, 2021 - Pages: 114 - US$ 2,000.00
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections - Pipeline Review, H2 2020 Published: November, 2020 - Pages: 492 - US$ 2,500.00
Streptococcus pyogenes Infections (Infectious Disease) - Drugs in Development, 2021 Published: March, 2021 - Pages: 34 - US$ 2,000.00
Chlamydia Trachomatis Infections (Infectious Disease) - Drugs in Development, 2021 Published: April, 2021 - Pages: 30 - US$ 2,000.00
Enterococcus Faecium Infections (Infectious Disease) - Drugs in Development, 2021 Published: April, 2021 - Pages: 45 - US$ 2,000.00
Enterovirus Infections (Infectious Disease) - Drugs in Development, 2021 Published: April, 2021 - Pages: 55 - US$ 2,000.00
Helicobacter Pylori Infections (Infectious Disease) - Drugs in Development, 2021 Published: April, 2021 - Pages: 60 - US$ 2,000.00

Middle East Respiratory Syndrome (MERS) (Infectious Disease) - Drugs in Development, 2021 Published: December, 2021 - Pages: 179 - US$ 2,000.00

Mark your calendar:

Temperature Control and Logistics Conference

07 June - 09 June, 2022
Dusseldorf, Germany